Utilidad clínica del test urinario ImmunocytTM en el protocolo de revisiones de pacientes con antecedentes de neoplasia uroteliales

Denholin, 1990, Morbidity following cystoscopy: comparison of flexible and rigid techniques, Br J Urol, 66, 152, 10.1111/j.1464-410X.1990.tb14893.x Westenfelder, 1987, Development of nosocomial and iatrogenic urinary tract infections (UTI) following urological interventions. A prospective clínical study, Scand J Neplirol, Suppl, 104, 59 Olsson, 2001, Immnunocyt a useful method in the follow-up protocol for Urol patients with urinary bladder carcinoma, Scand J Urol Nephrol, 35, 280, 10.1080/003655901750425846 Pode, 1999, Noninvasive detection of bladder cancer with the BTA stat test, J Urol, 161, 443, 10.1016/S0022-5347(01)61918-9 Saad, 2001, The early detection and diagnosis of bladder cancer: a critical review of the options, Eur Urol, 39, 619, 10.1159/000052519 Kausch, 2001, Bladder cancer II. Molecular aspects and dignosis, Eur Urol, 39, 498, 10.1159/000052495 Chopin, 2002, Superficial bladder tumors, Eur Urol, 42, 533, 10.1016/S0302-2838(02)00466-9 Vriesema, 2001, Diagnostic efficacy of the Immnunocyt test to detect superficial bladder cancer recurrence, Urology, 58, 367, 10.1016/S0090-4295(01)01217-1 Pfister, 2003, Immnunocyt test improves the diagnostic accuracy of urinary cytology: Results of a Frech multicenter study, J Urol, 169, 921, 10.1097/01.ju.0000048983.83079.4c Fradet, 1997, Performances characteristics of a new monoclonal antibody test for bladder cancer: Immnunocyt, Canad J Urol, 4, 400 Mian, 1999, Immnunocyt a new tool for detecting transitional cell cancer of the urinary tract, J Urol, 161, 1486, 10.1016/S0022-5347(05)68934-3 Fradet, 2002, Recent advances in the management of superficial bladder tumors, The Canadian Journal of Urology, 9, 1544 Nam, 2000, Comparison of molecular and convencional strategies for followup of superficial bladder cancer using decision analysis, J Urol, 163, 752, 10.1016/S0022-5347(05)67797-X